Georgetown University

🇬🇹Guatemala

Country: 🇬🇹Guatemala

Ownership: Private

Established: 1789-01-23

Employees: 5K

Market Cap: -

Website: http://www.georgetown.edu

Clinical Trials

Treatment Decision Making in Early-Stage Prostate Cancer

Phase 3

Completed

Conditions: Localized Prostate Cancer

Interventions: Behavioral: CD-ROM-based prostate ca treatment education+decision tools
Behavioral: CD-ROM-based prostate cancer treatment education

First Posted Date: 2005-09-20

Last Posted Date: 2010-01-13

Lead Sponsor: Georgetown University

Target Recruit Count: 168

Registration Number: NCT00196781

Locations: 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States

Prostate Cancer Screening: Fostering Informed Decisions

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: patient decision aid (print-based)

First Posted Date: 2005-09-20

Last Posted Date: 2010-01-20

Lead Sponsor: Georgetown University

Target Recruit Count: 543

Registration Number: NCT00196807

Locations: 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸
Howard University Hospital, Washington, District of Columbia, United States

Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects

Phase 1

Completed

Conditions: HIV Infection

First Posted Date: 2004-09-20

Last Posted Date: 2009-07-22

Lead Sponsor: Georgetown University

Target Recruit Count: 10

Registration Number: NCT00091741

Locations: 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States

Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

Interventions: Drug: Paclitaxel
Genetic: microarray analysis
Procedure: biopsy
Procedure: neoadjuvant therapy

First Posted Date: 2004-08-05

Last Posted Date: 2018-07-11

Lead Sponsor: Georgetown University

Target Recruit Count: 22

Registration Number: NCT00088829

Locations: 🇺🇸
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer

Phase 1

Completed

Conditions: Ovarian Cancer

First Posted Date: 2004-07-08

Last Posted Date: 2011-03-24

Lead Sponsor: Georgetown University

Target Recruit Count: 50

Registration Number: NCT00003297

Locations: 🇺🇸
Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia, United States

VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-05-25

Last Posted Date: 2011-03-24

Lead Sponsor: Georgetown University

Target Recruit Count: 45

Registration Number: NCT00004030

Locations: 🇺🇸
Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia, United States

Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors

Phase 2

Completed

Conditions: Esophageal Cancer
Pancreatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Gastric Cancer
Lung Cancer
Breast Cancer

First Posted Date: 2004-04-14

Last Posted Date: 2011-03-24

Lead Sponsor: Georgetown University

Target Recruit Count: 24

Registration Number: NCT00003125

Locations: 🇺🇸
Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States
🇺🇸
National Naval Medical Center, Bethesda, Maryland, United States

Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

First Posted Date: 2004-02-19

Last Posted Date: 2011-03-24

Lead Sponsor: Georgetown University

Target Recruit Count: 40

Registration Number: NCT00003035

Locations: 🇺🇸
Lombardi Cancer Center, Washington, District of Columbia, United States

Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer

Phase 2

Completed

Conditions: Breast Neoplasms

Interventions: Drug: Exemestane
Dietary Supplement: Calcium carbonate
Dietary Supplement: Vitamin D

First Posted Date: 2003-11-17

Last Posted Date: 2016-05-17

Lead Sponsor: Georgetown University

Target Recruit Count: 46

Registration Number: NCT00073073

Locations: 🇺🇸
Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States
🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-01-27

Last Posted Date: 2011-03-24

Lead Sponsor: Georgetown University

Registration Number: NCT00020748

Locations: 🇺🇸
Lombardi Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy